Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Sep 24, 2026
Aon (AON) Shares Drop Roughly 21% After $17 Billion USI Acquisition

Aon (AON) Shares Drop Roughly 21% After $17 Billion USI Acquisition

Key Takeaways

  • Aon plc (AON) shares fell roughly 21% over the last 30 days, retreating from about $359 to near $282 per share.
  • The decline was triggered by Aon's announcement of a $17 billion all-cash acquisition of USI Insurance Services, which raised leverage and suspended near-term share buybacks.
  • Credit-rating agencies adopted a more cautious stance, while several analysts lowered their price targets.
  • Over the last quarter, the stock rallied to a 52-week high near $382 in late July before reversing and ending down about 12%.
  • Strong second-quarter results and a reaffirmed 2026 outlook were overshadowed by financing and execution concerns tied to the deal.

Company Background: Aon plc (AON) Position in the Insurance Brokerage Space

Aon plc is a Dublin, Ireland-headquartered global professional services firm that provides risk, retirement, and health solutions to clients in more than 120 countries. Its core businesses span Commercial Risk Solutions, Reinsurance Solutions, Health Solutions, and Wealth Solutions, making it one of the world's largest insurance and reinsurance brokers alongside peers such as Marsh & McLennan. Aon generates revenue primarily through brokerage commissions and consulting fees, and it is widely followed for its organic growth, margin expansion, and capital-return discipline. Its scale, data and analytics capabilities, and client retention rates are key competitive strengths that investors monitor closely. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Stock Performance Review: Last 30 Days Compared to the Quarter

Over the last 30 days, AON declined from approximately $359.10 to $281.60, a drop of about 21.6%. Most of the damage occurred in a single session following the USI deal announcement, followed by continued selling pressure through September.

The quarterly picture tells a different story. Three months earlier, shares traded near $321. They rallied to a 52-week high of about $382 in late July after second-quarter earnings before reversing sharply. Net of that peak and the subsequent pullback, the stock ended the quarter down roughly 12%, trading near its 52-week lows.

The USI Deal Announcement and Immediate Market Reaction

The dominant catalyst was the acquisition announcement. On August 31, 2026, Aon confirmed an all-cash agreement to acquire USI Insurance Services from private equity firm KKR, with a net purchase price of about $16.7 billion. Shares fell about 9.5% on the first trading day after the announcement.

Investor concerns centered on financing and leverage. Aon plans to issue roughly $17.5 billion in new debt, which is expected to push leverage to an estimated 4.8 times adjusted EBITDA at closing, nearly double the prior level. S&P Global Ratings revised Aon's outlook to negative while affirming its A- rating, and Moody's shifted its outlook to stable from positive. The company also suspended share repurchases for the near term.

Analyst reactions were mixed but broadly cautious. Piper Sandler lowered its target to $349 from $391, Evercore ISI cut its target to $423, Cantor Fitzgerald to $433, and Mizuho to $398, while Deutsche Bank described the selloff as overdone. Chairman Lester Knight bought about $6.5 million of shares in early September, a move some investors read as confidence in the deal's strategic logic. From what I see, this insider purchase adds an interesting layer to the narrative around execution risk.

Pre-Deal Fundamentals and the Shift in Narrative

Before the USI announcement, Aon's shares had been supported by solid fundamentals. Second-quarter results reported in late July showed 5% organic revenue growth, a 9% increase in adjusted EPS to $3.81, and operating margin expansion. Management also reaffirmed its 2026 guidance for mid-single-digit or higher organic revenue growth and double-digit free cash flow growth.

That positive backdrop pushed the stock to a 52-week high near $382. The reversal reflects a shift in the investment narrative: a company long valued for predictable organic growth and reliable buybacks is now taking on substantial debt for a large acquisition, introducing integration and execution risk that has pressured its valuation multiple.

What to Watch Next for AON Investors

  • Deal completion: The USI acquisition is expected to close in the fourth quarter of 2026, subject to regulatory approvals, and integration progress will be closely watched.
  • Balance sheet: Investors will monitor leverage reduction and any updates to the credit outlook from S&P Global Ratings and Moody's.
  • Capital returns: The timing of any resumption of share buybacks is a key sentiment driver.
  • Organic growth and margins: Upcoming earnings will show whether the 5% organic growth and margin expansion trends persist.
  • Sector pricing: Trends in property and casualty and reinsurance pricing, along with macroeconomic conditions, will influence brokerage revenue.

Using AI Tools in My Research Process

In my own analysis of names like AON, I have turned to Tickeron’s AI Trading Bots to test automated strategies that align with different risk levels and timeframes. These tools help surface patterns across thousands of tickers and can complement traditional research when evaluating how a stock might behave around major corporate events. The platform offers a range of bots, allowing investors to explore approaches that fit their own style without replacing individual due diligence.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: AON

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


AON's RSI Oscillator is staying in oversold zone for 4 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +2.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where AON advanced for three days, in 154 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 47%.

AON may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 27, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AON as a result. In 42 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 46%.

AON moved below its 50-day moving average on August 31, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AON crossed bearishly below the 50-day moving average on August 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 32%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AON declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.

The Aroon Indicator for AON entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 23 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating fairly steady price growth. AON’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 88 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AON’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 89 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.321) is normal, around the industry mean (6.664). P/E Ratio (15.772) is within average values for comparable stocks, (34.174). Projected Growth (PEG Ratio) (2.244) is also within normal values, averaging (8.342). Dividend Yield (0.011) settles around the average of (0.010) among similar stocks. P/S Ratio (3.687) is also within normal values, averaging (2.968).

Notable companies

The most notable companies in this group are eHealth (NASDAQ:EHTH).

Industry description

Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.

Market Cap

The average market capitalization across the Insurance Brokers/Services Industry is 13.48B. The market cap for tickers in the group ranges from 3.03K to 89.51B. MMC holds the highest valuation in this group at 89.51B. The lowest valued company is CUII at 3.03K.

High and low price notable news

The average weekly price growth across all stocks in the Insurance Brokers/Services Industry was -7%. For the same Industry, the average monthly price growth was -21%, and the average quarterly price growth was 13%. CRVL experienced the highest price growth at 3%, while GSHD experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Insurance Brokers/Services Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 74% and the average quarterly volume growth was 25%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 72
P/E Growth Rating: 70
Price Growth Rating: 62
SMR Rating: 70
Profit Risk Rating: 88
Seasonality Score: -16 (-100 ... +100)
View a ticker or compare two or three
AON
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of insurance brokerage, risk management and human capital consulting services

Industry InsuranceBrokersServices

Industry
Insurance Brokers Or Services
Address
15 George's Quay
Phone
+353 12666000
Employees
60000
Web
https://www.aon.com
Interact to see
Advertisement
SMCI shares are plunging approximately 26% in Friday premarket trading, extending sharp after-hours losses from Thursday's session close of $30.79. The primary catalyst is a federal indictment unsealed March 19, 2026, charging three individuals associated with Super Micro — including a company co-founder — with conspiring to illegally export billions of dollars in AI server technology to China.
PL shares are surging approximately 19% in premarket trading on March 20, 2026, building on an 8.67% gain during the regular session on March 19. The primary catalyst is a blowout Q4 fiscal year 2026 earnings report released after the close on March 19, with quarterly revenue of $86.8 million — an 11.55% beat against consensus expectations of $77.81 million.
Unusual Machines (UMAC) is trading down approximately -8.60% in premarket on March 20, 2026, extending losses from the prior session. The primary catalyst is a proposed public stock offering announced after the market close on March 19, 2026, raising dilution concerns among investors.
FDX surged approximately 7% in premarket trading on March 20, 2026, moving from the prior session close of $356.11 to around $381. The primary catalyst is a blowout fiscal Q3 2026 earnings report, with adjusted EPS of $5.25 — beating Wall Street's consensus estimate of $4.13 by more than 27%.
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.